Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Sitryx Therapeutics Limited
Sitryx Therapeutics Limited is an active company incorporated on 8 September 2016 with the registered office located in Oxford, Oxfordshire. Sitryx Therapeutics Limited was registered 9 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
10366466
Private limited company
Age
9 years
Incorporated
8 September 2016
Size
Unreported
Confirmation
Due Soon
Dated
7 September 2024
(1 year ago)
Next confirmation dated
7 September 2025
Due by
21 September 2025
(13 days remaining)
Last change occurred
11 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Group
Next accounts for period
31 December 2025
Due by
30 September 2026
(1 year remaining)
Learn more about Sitryx Therapeutics Limited
Contact
Address
101 Bellhouse Building Magdalen Centre
The Oxford Science Park
Oxford
OX4 4GA
Same address for the past
4 years
Companies in OX4 4GA
Telephone
01865 648401
Email
Unreported
Website
Sitryx.com
See All Contacts
People
Officers
11
Shareholders
34
Controllers (PSC)
1
Mr Pierre Legault
Director • American • Lives in United States • Born in May 1960
Garrett Rhyasen
Director • Vice President Search, Evaluations & Tra • American,canadian • Lives in United States • Born in Jul 1987
Paul-Peter Tak
Director • SVP R&D Pipeline And Chief Immunology OF • Dutch • Lives in England • Born in Dec 1959
James Bradley Robling
Director • Corporate Business Development Professio • American • Lives in United States • Born in May 1972
Sanne Dejongh
Director • VC Partner • Dutch • Lives in Netherlands • Born in Nov 1988
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Mestag Therapeutics Ltd
Dame Catherine Elizabeth Bingham and Dr Andrew Neil Charles Weir are mutual people.
Active
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Quell Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Alchemab Therapeutics Ltd
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Eyebiotech Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£29.51M
Decreased by £4.8M (-14%)
Turnover
£23.31M
Increased by £23.31M (%)
Employees
46
Increased by 1 (+2%)
Total Assets
£34.53M
Decreased by £5.67M (-14%)
Total Liabilities
-£6.39M
Decreased by £10.4M (-62%)
Net Assets
£28.14M
Increased by £4.73M (+20%)
Debt Ratio (%)
19%
Decreased by 23.27% (-56%)
See 10 Year Full Financials
Latest Activity
Group Accounts Submitted
3 Months Ago on 5 Jun 2025
Iain Charles Kilty Appointed
11 Months Ago on 1 Oct 2024
Confirmation Submitted
11 Months Ago on 19 Sep 2024
Small Accounts Submitted
1 Year 2 Months Ago on 11 Jun 2024
Garrett Rhyasen Appointed
1 Year 4 Months Ago on 15 Apr 2024
Rabinder Kumar Prinjha Resigned
1 Year 4 Months Ago on 15 Apr 2024
Sanne Dejongh Appointed
1 Year 11 Months Ago on 18 Sep 2023
Confirmation Submitted
1 Year 12 Months Ago on 11 Sep 2023
Small Accounts Submitted
2 Years 1 Month Ago on 27 Jul 2023
Dr Rabinder Kumar Prinjha Appointed
2 Years 4 Months Ago on 11 May 2023
Get Alerts
Get Credit Report
Discover Sitryx Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Statement of capital following an allotment of shares on 30 May 2025
Submitted on 12 Jun 2025
Group of companies' accounts made up to 31 December 2024
Submitted on 5 Jun 2025
Statement of capital following an allotment of shares on 1 May 2025
Submitted on 4 Jun 2025
Statement of capital following an allotment of shares on 7 February 2025
Submitted on 11 Apr 2025
Statement of capital following an allotment of shares on 1 October 2024
Submitted on 31 Jan 2025
Appointment of Iain Charles Kilty as a director on 1 October 2024
Submitted on 18 Oct 2024
Resolutions
Submitted on 12 Oct 2024
Confirmation statement made on 7 September 2024 with updates
Submitted on 19 Sep 2024
Accounts for a small company made up to 31 December 2023
Submitted on 11 Jun 2024
Appointment of Garrett Rhyasen as a director on 15 April 2024
Submitted on 13 May 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs